newsfilter
← Latest News
GlobeNewswire·

Vaxart to Participate in BTIG Biotechnology Conference 2026

SOUTH SAN FRANCISCO, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX:VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery